WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2020

May 7, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2020-05-05

Reporting Person: Winters Chad (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-05	Common Stock	A	102.00	—	Acquired	591.8868	Direct

Footnotes

F1: This award vests in 3 equal annual installments beginning on 5/5/2021.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.